- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies for designing synthetic immune agonists
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume 148, Issue 4, Pages 315-325
Publisher
Wiley
Online
2016-05-24
DOI
10.1111/imm.12622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma
- (2016) Keith Biggadike et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antibody-Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy
- (2016) Taleen V. Jerjian et al. PHARMACOTHERAPY
- Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+T-cell axis
- (2016) Craig M. Brackett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biomaterial Strategies for Immunomodulation
- (2015) Nathan A. Hotaling et al. Annual Review of Biomedical Engineering
- Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
- (2015) Nathalie Isorce et al. ANTIVIRAL RESEARCH
- Guiding Principles in the Design of Molecular Bioconjugates for Vaccine Applications
- (2015) Haipeng Liu et al. BIOCONJUGATE CHEMISTRY
- Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides
- (2015) Hiroyuki Shinchi et al. BIOCONJUGATE CHEMISTRY
- Targeted Activation of Toll-Like Receptors: Conjugation of a Toll-Like Receptor 7 Agonist to a Monoclonal Antibody Maintains Antigen Binding and Specificity
- (2015) Adam J. R. Gadd et al. BIOCONJUGATE CHEMISTRY
- TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice
- (2015) Erina Koga-Yamakawa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synthetic Nanoparticles for Vaccines and Immunotherapy
- (2015) Darrell J. Irvine et al. CHEMICAL REVIEWS
- Pharmacokinetic, Pharmacodynamic, and Activity Evaluation of TMX-101 in a Multicenter Phase 1 Study in Patients With Papillary Non-Muscle-Invasive Bladder Cancer
- (2015) Tom J.H. Arends et al. Clinical Genitourinary Cancer
- Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement
- (2015) D Tsitoura et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Toll-like receptors as targets for allergen immunotherapy
- (2015) Zahra Aryan et al. Current Opinion in Allergy and Clinical Immunology
- Recent insights into structures and functions of C-type lectins in the immune system
- (2015) Kurt Drickamer et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study
- (2015) Lennart Greiff et al. INFLAMMATION RESEARCH
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
- (2015) Edward J. Gane et al. JOURNAL OF HEPATOLOGY
- Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
- (2015) Stephan Menne et al. JOURNAL OF HEPATOLOGY
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- Toll-like receptor 8 senses degradation products of single-stranded RNA
- (2015) Hiromi Tanji et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- NOD-Like Receptors: Versatile Cytosolic Sentinels
- (2015) Vinicius Motta et al. PHYSIOLOGICAL REVIEWS
- Drug flushes out hidden AIDS virus
- (2015) J. Cohen SCIENCE
- Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18–70 years of age
- (2015) Julia M. Janssen et al. VACCINE
- Injectable cryogel-based whole-cell cancer vaccines
- (2015) Sidi A. Bencherif et al. Nature Communications
- Toll-like receptor 8 senses degradation products of single-stranded RNA
- (2015) Hiromi Tanji et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses
- (2015) Tina M. Sali et al. PLoS Pathogens
- Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
- (2015) R. L. Sabado et al. Cancer Immunology Research
- Modulation of Innate Immune Responses via Covalently Linked TLR Agonists
- (2015) Janine K. Tom et al. ACS Central Science
- The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
- (2015) Vadim I. Krivokrysenko et al. PLoS One
- Directing the Immune System with Chemical Compounds
- (2014) Rock J. Mancini et al. ACS Chemical Biology
- Imiquimod induces a Toll-like receptor 7-independent increase in intracellular calcium via IP3 receptor activation
- (2014) Heehong Hwang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligands
- (2014) Afshin Nour et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure-Based Design of Novel Human Toll-like Receptor 8 Agonists
- (2014) Hari Prasad Kokatla et al. ChemMedChem
- A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma
- (2014) D. W. Northfelt et al. CLINICAL CANCER RESEARCH
- Immunomodulatory properties of the vaccine adjuvant alum
- (2014) Ewa Oleszycka et al. CURRENT OPINION IN IMMUNOLOGY
- Sensing viral invasion by RIG-I like receptors
- (2014) Ji-Seung Yoo et al. CURRENT OPINION IN MICROBIOLOGY
- The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
- (2014) Tanja Glavan et al. CURRENT PHARMACEUTICAL DESIGN
- Conjugation of a TLR7 agonist and antigen enhances protection in the S. pneumoniae murine infection model
- (2014) S. Vecchi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Toll-like receptor agonists: a patent review (2011 – 2013)
- (2014) Waleed M Hussein et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Vaccine adjuvant uses of poly-IC and derivatives
- (2014) Karen AO Martins et al. Expert Review of Vaccines
- Cancer vaccine adjuvants – recent clinical progress and future perspectives
- (2014) Abid H. Banday et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Endosomal Localization of TLR8 Confers Distinctive Proteolytic Processing on Human Myeloid Cells
- (2014) Noriko Ishii et al. JOURNAL OF IMMUNOLOGY
- Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
- (2014) Manisha Singh et al. JOURNAL OF IMMUNOLOGY
- Human Toll-Like Receptor 8-Selective Agonistic Activities in 1-Alkyl-1H-benzimidazol-2-amines
- (2014) Mallesh Beesu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stimulation of Innate Immune Cells by Light-Activated TLR7/8 Agonists
- (2014) Keun Ah Ryu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
- (2014) Jaeyun Kim et al. NATURE BIOTECHNOLOGY
- Rational design of small molecules as vaccine adjuvants
- (2014) T. Y.- H. Wu et al. Science Translational Medicine
- Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
- (2014) Petr O. Ilyinskii et al. VACCINE
- Covalently Coupled Immunostimulant Heterodimers
- (2013) Rock J. Mancini et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells
- (2013) Ryan M. Stephenson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting Toll-like receptors with small molecule agents
- (2013) Xiaohui Wang et al. CHEMICAL SOCIETY REVIEWS
- GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
- (2013) Robert E. Lanford et al. GASTROENTEROLOGY
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification and Optimization of Pteridinone Toll-like Receptor 7 (TLR7) Agonists for the Oral Treatment of Viral Hepatitis
- (2013) Paul A. Roethle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Substituted Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands
- (2013) Michael Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Development of Stable, Water-Soluble, Human Toll-like Receptor 2 Specific Monoacyl Lipopeptides as Candidate Vaccine Adjuvants
- (2013) Deepak B. Salunke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exquisite Selectivity for Human Toll-Like Receptor 8 in Substituted Furo[2,3-c]quinolines
- (2013) Hari Prasad Kokatla et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes
- (2013) David J. Dowling et al. PLoS One
- Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands
- (2013) H. Tanji et al. SCIENCE
- STING-dependent cytosolic DNA sensing pathways
- (2013) Glen N. Barber TRENDS IN IMMUNOLOGY
- Aldara activates TLR7-independent immune defence
- (2013) Anne Walter et al. Nature Communications
- Releasable Layer-by-Layer Assembly of Stabilized Lipid Nanocapsules on Microneedles for Enhanced Transcutaneous Vaccine Delivery
- (2012) Peter C. DeMuth et al. ACS Nano
- Novel glycolipid TLR2 ligands of the type Pam2Cys-α-Gal: Synthesis and biological properties
- (2012) Jean-Sébastien Thomann et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Generation of tumor-targeted antibody–CpG conjugates
- (2012) Zhongjun Li et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Structure–Activity Relationships in Human Toll-like Receptor 2-Specific Monoacyl Lipopeptides
- (2012) Deepak B. Salunke et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
- (2012) David R. Strayer et al. PLoS One
- Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity
- (2012) Martin Kreutz et al. PLoS One
- Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
- (2012) Nikunj M. Shukla et al. PLoS One
- Molecular and Cellular Response Profiles Induced by the TLR4 Agonist-Based Adjuvant Glucopyranosyl Lipid A
- (2012) Stacie L. Lambert et al. PLoS One
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
- (2012) J. J. Moon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV
- (2011) J. F. Bergmann et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
- (2011) C. Manegold et al. ANNALS OF ONCOLOGY
- Synthesis and Characterization of PEGylated Toll Like Receptor 7 Ligands
- (2011) Michael Chan et al. BIOCONJUGATE CHEMISTRY
- Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection
- (2011) Thien-Duc Tran et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Simple synthetic toll-like receptor 2 ligands
- (2011) Abu-Baker M. Abdel-Aal et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity
- (2011) M Biffen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance
- (2011) C. Bourquin et al. CANCER RESEARCH
- VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
- (2011) H. Lu et al. CLINICAL CANCER RESEARCH
- The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)
- (2011) M D Fidock et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile
- (2011) Nathalie Garçon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Vaccine adjuvants: The dream becomes real
- (2011) Aldo Tagliabue et al. Human vaccines & immunotherapeutics
- Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
- (2011) Vera Hirsh et al. JOURNAL OF CLINICAL ONCOLOGY
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles
- (2011) C. M. Jewell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
- (2011) Dmitri Smirnov et al. VACCINE
- Novel powerful water-soluble lipid immunoadjuvants inducing mouse dendritic cell maturation and B cell proliferation using TLR2 pathway
- (2010) Maria Vittoria Spanedda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens
- (2010) Chittappen K. Prajeeth et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Identification of Novel Synthetic Toll-like Receptor 2 Agonists by High Throughput Screening
- (2010) Yue Guan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075
- (2010) S. Spranger et al. JOURNAL OF IMMUNOLOGY
- The Capacity To Induce Cross-Presentation Dictates the Success of a TLR7 Agonist-Conjugate Vaccine for Eliciting Cellular Immunity
- (2010) J. Z. Oh et al. JOURNAL OF IMMUNOLOGY
- Synthesis and Biological Evaluation of 8-Oxoadenine Derivatives as Toll-like Receptor 7 Agonists Introducing the Antedrug Concept
- (2010) Ayumu Kurimoto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure−Activity Relationships in Toll-like Receptor-2 Agonistic Diacylthioglycerol Lipopeptides
- (2010) Wenyan Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2
- (2010) Tomoko Hayashi et al. MELANOMA RESEARCH
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
- (2009) Michael Chan et al. BIOCONJUGATE CHEMISTRY
- The immunology of smallpox vaccines
- (2009) Richard B Kennedy et al. CURRENT OPINION IN IMMUNOLOGY
- The path to a successful vaccine adjuvant – ‘The long and winding road’
- (2009) Derek T. O’Hagan et al. DRUG DISCOVERY TODAY
- Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
- (2009) Jin Young Kang et al. IMMUNITY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice
- (2009) O. A. Ali et al. Science Translational Medicine
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now